Curcumin Reprograms TAMs from a Protumor Phenotype towards an Antitumor Phenotype via Inhibiting MAO-A/STAT6 Pathway

Area of Science:

• Immunology
• Oncology
• Pharmacology

Background:

• Tumor-associated macrophages (TAMs) play a crucial role in cancer progression, with M2 phenotypes promoting tumor growth and metastasis.
• A higher M1/M2 macrophage ratio is associated with an improved anti-tumor immune microenvironment.
• Curcumin exhibits anticancer properties, but its underlying mechanisms, particularly its effect on TAMs, require elucidation.

Purpose of the Study:

• To investigate the effect of curcumin on the phenotype of tumor-associated macrophages (TAMs).
• To explore the potential of curcumin in reprogramming M2 macrophages towards an M1 phenotype.
• To elucidate the molecular mechanisms by which curcumin exerts its anticancer effects via TAM modulation.

Main Methods:

• Utilized a cell co-culture system and an M2 macrophage model to assess curcumin's impact.
• Quantified changes in pro-inflammatory (TNF-α, iNOS, IL-6) and anti-inflammatory (TGF-β, Arg-1, IL-10) cytokines.
• Measured surface markers (CD86 for M1, CD206 for M2) and assessed tumor cell migration and invasion.
• Investigated the role of monoamine oxidase A (MAO-A)/STAT6 signaling pathway.

Main Results:

• Curcumin treatment successfully reprogrammed M2 macrophages towards an M1 phenotype.
• Curcumin reduced M2 markers (e.g., CD206, IL-10) and increased M1 markers (e.g., CD86, TNF-α).
• Curcumin suppressed the migration and invasion of cancer cells induced by M2-like macrophages, likely via inhibition of MAO-A/STAT6 signaling.

Conclusions:

• Curcumin effectively repolarizes TAMs from a protumor M2 phenotype to an antitumor M1 phenotype.
• The anticancer effects of curcumin are, in part, mediated by modulating TAM polarization.
• Curcumin's mechanism involves the inhibition of the MAO-A/STAT6 signaling pathway, offering a potential therapeutic strategy.